BCAX
Bicara Therapeutics Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.42B
P/E Ratio
—
EPS
$-2.77
Beta
—
52W High
$24.25
52W Low
$8.48
50-Day MA
$21.20
200-Day MA
$16.99
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-173.93M |
| Operating Margin | 0.00% |
| Return on Equity | -32.30% |
| Return on Assets | -21.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $7.84 |
| Price-to-Book | 2.77 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $65.70M |
| Float | $36.63M |
| % Insiders | 10.22% |
| % Institutions | 103.91% |
Historical Volatility
HV 10-Day
56.63%
HV 20-Day
48.82%
HV 30-Day
46.82%
HV 60-Day
45.57%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($31.46 target)
3
Strong Buy8
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026